Peroxisome proliferator-activated receptor α protects against alcohol-induced liver damage

被引:189
作者
Nakajima, T
Kamijo, Y
Tanaka, N [1 ]
Sugiyama, E
Tanaka, E
Kiyosawa, K
Fukushima, Y
Peters, JM
Gonzalez, FJ
Aoyama, T
机构
[1] Shinshu Univ, Grad Sch Med, Inst Aging & Adaptat, Dept Metab Regulat, Matsumoto, Nagano 3908621, Japan
[2] Shinshu Univ, Sch Med, Dept Hyg & Med Genet, Matsumoto, Nagano 3908621, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Environm & Occupat Hlth, Nagoya, Aichi, Japan
[4] Shinshu Univ, Sch Med, Dept Internal Med, Matsumoto, Nagano 3908621, Japan
[5] Nagano Prefectural Coll, Course Sci Living, Nagano, Japan
[6] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet Sci, University Pk, PA 16802 USA
[7] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1002/hep.20399
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The mechanisms underlying alcoholic liver disease are not completely understood, but lipid accumulation seems to be central to the cause of this disease. The peroxisome proliferator-activated receptor alpha (PPARalpha) plays an important role in the control of lipid homeostasis, metabolism of bioactive molecules, and modulation of inflammatory responses. To investigate the roles of PPARaalpha in alcoholic liver injury, wild-type and PPARalpha-null mice were continuously fed a diet containing 4% ethanol, and liver injury was analyzed. PPARalpha-null mice fed ethanol exhibited marked hepatomegaly, hepatic inflammation, cell toxicity, fibrosis, apoptosis, and mitochondrial swelling. Some of these hepatic abnormalities were consistent with those of patients with alcoholic liver injury and were not found in wild-type mice. Next, the molecular mechanisms of ethanol-induced liver injury in PPARalpha-null mice were investigated, and changes related to ethanol and acetaldehyde metabolism, oxidative stress, inflammation, hepatocyte proliferation, fibrosis, and mitochondrial permeability transition activation occurred specifically in PPARalpha-null mice as compared with wild-type mice. In conclusion, these studies suggest a protective role for PPARalpha in alcoholic liver disease. Humans may be more susceptible to liver toxicity induced by ethanol as PPARalpha expression in human liver is considerably lower compared to that of rodents.
引用
收藏
页码:972 / 980
页数:9
相关论文
共 53 条
[1]   Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα) [J].
Aoyama, T ;
Peters, JM ;
Iritani, N ;
Nakajima, T ;
Furihata, K ;
Hashimoto, T ;
Gonzalez, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) :5678-5684
[2]   Molecular basis of non-responsiveness to peroxisome proliferators:: the guinea-pig PPARα is functional and mediates peroxisome proliferator-induced hypolipidaemia [J].
Bell, AR ;
Savory, R ;
Horley, NJ ;
Choudhury, AI ;
Dickins, M ;
Gray, TJB ;
Salter, AM ;
Bell, DR .
BIOCHEMICAL JOURNAL, 1998, 332 :689-693
[3]  
BRUGUERA M, 1977, GASTROENTEROLOGY, V73, P1383
[4]   Grading and staging the histopathological lesions of chronic hepatitis. The Knodell histology activity index and beyond [J].
Brunt, EM .
HEPATOLOGY, 2000, 31 (01) :241-246
[5]   Fas enhances fibrogenesis in the bile duct ligated mouse: A link between apoptosis and fibrosis [J].
Canbay, A ;
Higuchi, H ;
Bronk, SF ;
Taniai, M ;
Sebo, TJ ;
Gores, GJ .
GASTROENTEROLOGY, 2002, 123 (04) :1323-1330
[6]   Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation [J].
Chinetti, G ;
Fruchart, JC ;
Staels, B .
INFLAMMATION RESEARCH, 2000, 49 (10) :497-505
[7]   Be fit or be sick: Peroxisome proliferator-activated receptors are down the road [J].
Desvergne, B ;
Michalik, L ;
Wahli, W .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (06) :1321-1332
[8]   The PPAR alpha-leukotriene B-4 pathway to inflammation control [J].
Devchand, PR ;
Keller, H ;
Peters, JM ;
Vazquez, M ;
Gonzalez, FJ ;
Wahli, W .
NATURE, 1996, 384 (6604) :39-43
[9]   Liver disease in alcohol abusers: clinical perspective [J].
Diehl, AM .
ALCOHOL, 2002, 27 (01) :7-11
[10]  
Factor VM, 1997, CANCER RES, V57, P2089